State Medicaid programs are undergoing fundamental transition. States are reshaping their Medicaid programs and their entire health systems by developing new models of providing benefits. The federal government continues to place Medicaid reform at the top of its agenda as it seeks broader cost savings. With the advent of the new Medicare prescription drug benefit, states must maneuver real-time challenges in managing their beneficiaries' health, while adjusting to the benefit's new financial requirements for states. These changes affect all health care stakeholders who must develop new policy and commercial strategies in response to the new evolution in Medicaid.

Join national thought leaders for an engaging three-day session that will address critical questions about emerging Medicaid reform models, the expanded role of Medicaid managed care, new federal and state strategies to manage costs, the impact of the Medicare prescription drug benefit, and the future of Medicaid long-term care.

MEDICAID CONGRESS PRECONFERENCE SESSIONS:

• Medicaid Prescription Drug Primer: How does Medicaid reimburse for prescription drugs work? Learn the basics of the Medicaid rebate program, 340b, federal upper payment limits, treatment of drugs by MCOs, and policy issues and implications.
• Medicaid Reform Primer: How do the federal government and states modify state Medicaid programs? What is the role of Congress, CMS, state legislatures and state Medicaid agencies? What changes require a state plan amendment, a federal waiver, or a change in federal law? The session will use as examples previous Medicaid reform initiatives, such as Tennessee, Oregon, and Arizona's 1115 waivers.

MEDICAID CONGRESS TRACK SESSIONS:

• New Directions in Medicaid and State Health Reform
• Medicaid Cost Containment Strategies
• Implementation of the Medicare Prescription Drug Benefit and the impact on states and dual eligible beneficiaries
• Medicaid and Long-Term Care
• New approaches to Medicaid managed care: The Florida and South Carolina Models
• New approaches to pharmacy management and cost containment
• Dual eligible and low-income beneficiaries experiences in the Medicare new prescription drug benefit to date
• Effects of Medicare Part D on Dual Eligibles in Community and Facility LTC Settings
• New Approaches to Medicaid: The Utah and Idaho Models
• Evidence-based practices and new definitions of medical necessity
• State Pharmaceutical Assistance Programs and other state strategies to supplement the new benefit
• Innovations in Medicaid-Medicare Integration: Breakthroughs At Last?
• New Approaches to Medicaid: Medicare and Medicaid Integration Models
• New opportunities for disease management and care coordination programs in Medicare
• Special Needs Plans and new innovations in designing prescription drug benefits for dual eligible beneficiaries
• State Leadership in LTC Reform - A Case Study of Vermont's Medicaid Waiver Program
• New Approaches to State Health Reform: Extending Coverage to the Uninsured and Reducing state health care costs
• Medicaid Managed Care - opportunities and implications of state expansions
• Future directions for the Part D benefit
• LTC Industry Perspectives on Medicaid LTC Issues (including dual eligibles in LTC)

Powered by

Sponsored by

---

---